Prestige Consumer Healthcare (PBH), a leading provider of over-the-counter health products, is making strides due to persistent consumer ...

Q3 2025 Earnings Call Transcript February 6, 2025 Prestige Consumer Healthcare Inc. beats earnings expectations. Reported EPS ...

The offering, Consumer-Directed Health, will provide employers and individuals an array of products and services that allow ...

Lupin transfers OTC business to subsidiary for Rs ₹550-650 crore, reports strong Q3 financial performance with profit and ...

D.A. Davidson analyst Linda Bolton Weiser maintained a Buy rating on Prestige Consumer Healthcare (PBH – Research Report) today and set a price ...

For the quarter ended December 2024, Prestige Consumer Healthcare (PBH) reported revenue of $290.32 million, up 2.7% over the same period last year. EPS came in at $1.22, compared to $1.06 in the year ...

The fate of a Biden-era rule that would keep medical debt from consumers’ credit reports is up in the air amid reported ...

Thank you for standing by and welcome to Prestige Consumer Healthcare third quarter, 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker ...

For the quarter ended December 2024, Prestige Consumer Healthcare (PBH) reported revenue of $290.32 million, up 2.7% over the same period last year. EPS came in at $1.22, compared to $1.06 in the ...